Biophytis (BPTSY) Competitors $1.70 -0.24 (-12.37%) As of 05/22/2025 09:30 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock BPTSY vs. PWUP, INM, QLGN, KTTA, VCNX, PTN, AWH, SCNI, APVO, and GLMDShould you be buying Biophytis stock or one of its competitors? The main competitors of Biophytis include PowerUp Acquisition (PWUP), InMed Pharmaceuticals (INM), Qualigen Therapeutics (QLGN), Pasithea Therapeutics (KTTA), Vaccinex (VCNX), Palatin Technologies (PTN), Aspira Women's Health (AWH), Scinai Immunotherapeutics (SCNI), Aptevo Therapeutics (APVO), and Galmed Pharmaceuticals (GLMD). These companies are all part of the "pharmaceutical products" industry. Biophytis vs. PowerUp Acquisition InMed Pharmaceuticals Qualigen Therapeutics Pasithea Therapeutics Vaccinex Palatin Technologies Aspira Women's Health Scinai Immunotherapeutics Aptevo Therapeutics Galmed Pharmaceuticals Biophytis (NASDAQ:BPTSY) and PowerUp Acquisition (NASDAQ:PWUP) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, community ranking, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends. Which has better valuation and earnings, BPTSY or PWUP? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiophytisN/AN/A-$18.43MN/AN/APowerUp AcquisitionN/AN/AN/AN/AN/A Is BPTSY or PWUP more profitable? Company Net Margins Return on Equity Return on Assets BiophytisN/A N/A N/A PowerUp Acquisition N/A N/A N/A Do institutionals & insiders hold more shares of BPTSY or PWUP? 0.1% of Biophytis shares are held by institutional investors. Comparatively, 19.2% of PowerUp Acquisition shares are held by institutional investors. 3.7% of Biophytis shares are held by company insiders. Comparatively, 48.0% of PowerUp Acquisition shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media prefer BPTSY or PWUP? In the previous week, Biophytis' average media sentiment score of 0.00 equaled PowerUp Acquisition'saverage media sentiment score. Company Overall Sentiment Biophytis Neutral PowerUp Acquisition Neutral Which has more volatility & risk, BPTSY or PWUP? Biophytis has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Comparatively, PowerUp Acquisition has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500. Does the MarketBeat Community prefer BPTSY or PWUP? Biophytis and PowerUp Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformBiophytisN/AN/APowerUp AcquisitionN/AN/A SummaryPowerUp Acquisition beats Biophytis on 2 of the 3 factors compared between the two stocks. Get Biophytis News Delivered to You Automatically Sign up to receive the latest news and ratings for BPTSY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BPTSY vs. The Competition Export to ExcelMetricBiophytisPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$597,000.00$6.47B$5.33B$8.39BDividend YieldN/A2.64%5.21%4.11%P/E RatioN/A9.0626.8019.71Price / SalesN/A251.66397.78120.67Price / CashN/A65.8538.2534.62Price / Book-0.116.456.774.50Net Income-$18.43M$143.98M$3.23B$248.22M7 Day PerformanceN/A0.38%0.48%-0.78%1 Month Performance-49.40%2.14%9.13%11.53%1 Year Performance-77.69%-0.33%18.58%8.99% Biophytis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BPTSYBiophytisN/A$1.70-12.4%N/A-77.7%$597,000.00N/A0.0030PWUPPowerUp AcquisitionN/A$0.36+6.3%N/A-98.1%$2.77MN/A0.00N/AHigh Trading VolumeINMInMed Pharmaceuticals0.4091 of 5 stars$2.28-3.0%N/A-60.6%$2.75M$4.83M-0.1710Positive NewsGap DownQLGNQualigen TherapeuticsN/A$3.65+1.7%N/A-72.9%$2.69M$4.98M0.0050KTTAPasithea Therapeutics1.5901 of 5 stars$0.87+4.7%N/A-85.7%$2.57MN/A-0.073VCNXVaccinexN/A$0.98+44.1%N/A-87.8%$2.55M$388,000.00-0.0240Gap UpPTNPalatin TechnologiesN/A$0.09-44.6%N/AN/A$2.45M$350,000.00-0.0630Analyst ForecastGap DownHigh Trading VolumeAWHAspira Women's Health0.9259 of 5 stars$0.08-12.5%$5.50+6,607.3%-96.8%$2.44M$9.18M-0.07110High Trading VolumeSCNIScinai Immunotherapeutics0.2795 of 5 stars$2.54-1.6%N/A-17.7%$2.41M$452,000.00-0.0120News CoverageAPVOAptevo Therapeutics2.1491 of 5 stars$0.34flat$10,952.00+3,221,076.5%-100.0%$2.13M$3.11M0.0050News CoverageGap DownGLMDGalmed Pharmaceuticals0.8018 of 5 stars$1.28+3.2%N/A-70.4%$2.12MN/A-0.0820News CoverageEarnings ReportUpcoming EarningsGap Down Related Companies and Tools Related Companies PowerUp Acquisition Alternatives InMed Pharmaceuticals Alternatives Qualigen Therapeutics Alternatives Pasithea Therapeutics Alternatives Vaccinex Alternatives Palatin Technologies Alternatives Aspira Women's Health Alternatives Scinai Immunotherapeutics Alternatives Aptevo Therapeutics Alternatives Galmed Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BPTSY) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biophytis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biophytis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BPTSY Stock Free BPTSY Stock Alerts